Giant cell arteritis and its mimics: a comparison of three patient cohorts

MJ Koster, K Yeruva, CS Crowson, F Muratore… - Seminars in Arthritis and …, 2020 - Elsevier
Objective To compare temporal artery biopsy (TAB)-positive giant cell arteritis (GCA) to TAB-
negative GCA and patients with GCA mimics Methods: Patients diagnosed with TAB-positive …

Mechanism and biomarkers in aortitis––a review

B Benhuri, A ELJack, B Kahaleh… - Journal of Molecular …, 2020 - Springer
Aortitis can be the manifestation of an underlying infectious or noninfectious disease
process. An autoimmune cause is suggested in a large proportion of noninfectious causes …

18F-fluorodeoxyglucose PET/computed tomography in the diagnosis and monitoring of giant cell arteritis

BD Nielsen, LC Gormsen - PET clinics, 2020 - pet.theclinics.com
Giant cell arteritis (GCA) is an autoimmune disease, causing systemic inflammation of large
and medium-sized vessels in the elderly (age> 50 years) Attempting to determine the …

Treatment of giant-cell arteritis, a literature review

B Watelet, M Samson, H de Boysson… - Modern …, 2017 - academic.oup.com
Giant-cell arteritis (GCA) is the most common vasculitis in people aged more than 50 years.
Despite the frequency of this disease, there is currently no international consensus on its …

Risk factors for symptomatic vascular events in giant cell arteritis: a study of 254 patients with large-vessel imaging at diagnosis

D de Mornac, C Agard, JB Hardouin… - Therapeutic …, 2021 - journals.sagepub.com
Aims: To identify factors associated with vascular events in patients with giant cell arteritis
(GCA). Methods: We performed a retrospective study of GCA patients diagnosed over a 20 …

Systemic vasculitis and the eye

I Tugal-Tutkun - Current Opinion in Rheumatology, 2017 - journals.lww.com
Widely used fast-track pathway care as well as ocular imaging to detect subclinical
involvement may enable earlier diagnosis of GCA and prevention of permanent visual loss …

Impact of giant cell arteritis and its treatment on the patient's quality of life: a single-center self-assessment study

H de Boysson, C Barakat, A Dumont, J Boutemy… - Frontiers in …, 2021 - frontiersin.org
Little is known about the impact of giant cell arteritis (GCA) and its treatment on patient-
reported physical, mental, and psychic quality of life (QoL). In this monocentric study, a …

Duration of treatment with glucocorticoids in giant cell arteritis: A systematic review and meta-analysis

L Moreel, A Betrains, G Molenberghs… - JCR: Journal of …, 2023 - journals.lww.com
The aim of this meta-analysis was to estimate the mean duration of glucocorticoid (GC)
treatment in patients with giant cell arteritis. PubMed, EMBASE, and Cochrane databases …

Updates in the diagnosis and management of giant cell arteritis

S Uppal, M Hadi, S Chhaya - Current Neurology and Neuroscience …, 2019 - Springer
Abstract Purpose of Review Giant cell arteritis is a systemic large vessel vasculitis that
affects the older population and can cause progressive and at times, devastating …

Interleukin-6: a promising target for the treatment of polymyalgia rheumatica or giant cell arteritis?

É Toussirot, A Régent, V Devauchelle-Pensec… - RMD open, 2016 - rmdopen.bmj.com
Polymyalgia rheumatica (PMR) is a chronic inflammatory disease of unknown aetiology
affecting people aged over 50. The hallmark manifestations of PMR are pain and stiffness …